The board of directors of AstraZeneca Pharma India will meet on May 5 to consider seeking approval of shareholders of the company through postal ballot, for the voluntary delisting proposed by AstraZeneca Pharmaceuticals AB Sweden, promoter of the company. The stock on Friday closed at ₹1,127.5 on the BSE.
The board of directors of Deepak Nitrite Ltd on Friday approved a 1:1 bonus ratio for the shareholders of the company. The board also approved the sub-division of equity of shares’ face value from ₹10 to ₹2 and a dividend of ₹10 a share of face value of ₹10. The recommendations, however, are subject to the approval of shareholders. Since the record date for the allotment of bonus shares and sub-division of shares will fall prior to the book closure date for the payment of dividend, the shareholders will be entitled to dividend of ₹1 per share of face value of ₹2 each. The stock on Friday closed at ₹532.55, up one per cent over the previous day’s close.